|
|
 |
|
Viewing report
|
|
 |
 |
Medical Affairs: Delivering Strategic Value
Cutting Edge Information, March 2008, Pages: 119
Metrics Overview Medical Affairs contains the following metrics:
- Medical Affairs Reporting Structures 2002 vs. 2008 - Companies’ Medical Affairs Structures - Medical Affairs Internal Alignment - Medical Affairs Reporting Structure in 2002 - Medical Affairs Reporting Structure in 2008 - Company I’s US Medical Affairs Structure - Company K’s Scientific Affairs Structure - Medical Affairs Funding Source(s) - Company Medical Affairs Funding Source(s) - 2008 US Medical Affairs Budgets - 2008 US Medical Affairs Budget Allocation - Company Medical Affairs Budget Allocations by Function - Average US Medical Affairs Budget by Activity - 2008 Medical Affairs Budget Allocation ($10 Million or Less) - 2008 Medical Affairs Budget Allocation (More Than $10 Million) - 2008 US Thought Leader Spending - 2008 US MSL Programs Spending - 2008 US Medical Publications Spending - 2008 US Medical Education Spending - 2008 US Medical Information Spending - 2008 US Investigator-Initiated Trials Spending - 2008 US Medical Grants Spending - 2008 US Other Spending - 2008 US Medical Affairs Budgets and Staffing Resource Allocation - 2008 Medical Affairs Staffing - 2008 US Medical Affairs Staffing Allocation - Company Medical Affairs Staffing Allocations by Function - Average US Medical Affairs Staffing by Activity - 2008 US Medical Affairs Staffing Allocation - 2008 US Thought Leader Headcounts - 2008 US MSL Program Headcounts - 2008 US Medical Publications Headcounts - 2008 US Medical Education Headcounts - 2008 US Medical Information Headcounts - 2008 US Investigator-Initiated Trials Headcounts - 2008 US Medical Grants Headcounts - 2008 US Other Headcounts - Percentage of Average US Medical Affairs Budget Outsourced in 2008 - Percentage of 2008 US Medical Affairs Budget Outsourced by Company - Outsourced US Medical Affairs Budget in 2008 - Weighing Outsourcing Advantages vs. Disadvantages - Medical Affairs Strategy, Activities and Compliance - Aligning Medical Affairs with Brand Strategy - Thought Leaders: First Involvement During Drug Development - Thought Leaders: Last Involvement With a Drug - MSL Programs: First Involvement During Drug Development - MSL Programs: Last Involvement With a Drug - Medical Publications: First Involvement During Drug Development - Medical Publications: Last Involvement With a Drug - Medical Education: First Involvement During Drug Development - Medical Education: Last Involvement With a Drug - Medical Information: First Involvement During Drug Development - Medical Information: Last Involvement With a Drug - Investigator-Initiated Trials: First Involvement During Drug Development - Investigator-Initiated Trials: Last Involvement With a Drug - Medical Grants: First Involvement During Drug Development - Medical Grants: Last Involvement With a Drug - Medical Affairs Compliance - Impact of OIG Guidelines - Impact of Uniform Requirements from International Committee of Medical Journal Editors (ICMJE) - Impact of Good Publication Practices (GPP) - Impact of CONSORT Statement - Impact of Food and Drug Administration Modernization Act (FDAMA) - Impact of PhRMA code - Impact of GCP Code
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Medical Affairs Resources, Structures and Trends
Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success
Pharmaceutical Regulatory Affairs in the EU & US
Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices
Pharmaceutical Medical Publications: Market Preparation & Strategic Support
Veterans Affairs: Agency Account Planner
The Changing MSL Role: Proving Value through Performance Measurement
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in the Fourth Quarter of 2004
The Toolkit for Diabetes MSL Programs (PH130)
Medical Imaging Markets
Global Trends in Reimbursement of Medical Technology
|
 |
|
|